Targeting Functional Biomarkers in Schizophrenia with Neuroimaging

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|14|2117-2123

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.14, 2016-04, pp. : 2117-2123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Psychoactive Substances in Schizophrenia – Findings of Structural and Functional Neuroimaging

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 21, 2012-01 ,pp. : 2426-2433

Bentham Science Publishers

Access to resources Recommend Favorite

Functional Neuroimaging of Sleep Disorders

By  

Current Pharmaceutical Design, Vol. 14, Iss. 32, 2008-11 ,pp. : 3417-3429

Bentham Science Publishers

Access to resources Recommend Favorite

Transcranial Magnetic Stimulation in Schizophrenia: The Contribution of Neuroimaging

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 21, 2012-11 ,pp. : 2452-2457

Bentham Science Publishers

Access to resources Recommend Favorite

The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1500-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Neurochemistry of Schizophrenia: The Contribution of Neuroimaging Postmortem Pathology and Neurochemistry in Schizophrenia

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 21, 2012-11 ,pp. : 2375-2392

Bentham Science Publishers

Access to resources Recommend Favorite